 | Silverback Therapeutics, Inc. | |||
| NasdaqGM : SBTX || Location: United States | ||||
$4.8-0.01 (-0.21%) |
0.0 M | 4.73 - 4.89 | ||
| Last Updated:08/10/2022 09:46 | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| July 15, 2022 | 0.554 M |
| June 30, 2022 | 0.771 M |
| June 15, 2022 | 1.139 M |
| May 31, 2022 | 1.063 M |
| May 13, 2022 | 1.271 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 03/31/2022 | -0.54 | -0.70 | -29.60% |
| 12/31/2021 | -0.70 | -0.67 | 4.30% |
| 09/30/2021 | -0.67 | -0.65 | 3.00% |
| 06/30/2021 | -0.53 | -0.70 | -32.10% |
| 03/31/2021 | -0.35 | -0.54 | -54.30% |
SBTX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 35.187M | Shares Float | 20.840M |
| Short Float | 0.554M | Market Cap | 175.23M |
| Institution ownership | 89.69% | Insider ownership | 3.630% |
| Earnings Date | 08/10/2022 | Cash Per Share | ? |
| Trailing EPS | -2.73 | Forward EPS | -1.75 |